Sanofi
- Country
- 🇫🇷France
- Ownership
- Public
- Employees
- 87.9K
- Market Cap
- $141.3B
- Website
- http://www.sanofi.com
- Introduction
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients
- Conditions
- Bipolar Disorder
- First Posted Date
- 2005-08-02
- Last Posted Date
- 2008-04-10
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 120
- Registration Number
- NCT00126009
- Locations
- 🇪🇸
Sanofi-Aventis, Barcelona, Spain
STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)
- Conditions
- Coronary Atherosclerosis
- First Posted Date
- 2005-07-27
- Last Posted Date
- 2009-04-20
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 839
- Registration Number
- NCT00124332
- Locations
- 🇧🇪
sanofi-aventis, Belgium, Diegem, Belgium
🇵🇱sanofi-aventis Poland, Warszawa, Poland
🇨🇦Sanofi-Aventis Administrative Office, Laval, Canada
Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction
- Conditions
- Coronary Atherosclerosis
- First Posted Date
- 2005-07-25
- Last Posted Date
- 2008-08-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 1257
- Registration Number
- NCT00123565
- Locations
- 🇹🇷
Sanofi-Aventis, Istanbul, Turkey
🇫🇷Sanofi-Aventis France, Paris, France
🇪🇸Sanofi-aventis, Barcelona, Spain
Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents
- Conditions
- Diabetes Mellitus, Insulin-Dependent
- Interventions
- First Posted Date
- 2005-06-24
- Last Posted Date
- 2016-05-20
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 572
- Registration Number
- NCT00115570
- Locations
- 🇺🇸
Childrens Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO)
- Conditions
- Congenital Heart DefectsBlood Platelet Disorders
- First Posted Date
- 2005-06-22
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 92
- Registration Number
- NCT00115375
- Locations
- 🇮🇹
Sanofi-Aventis Administrative Office, Milano, Italy
Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
- Conditions
- Alzheimer Disease
- First Posted Date
- 2005-02-21
- Last Posted Date
- 2008-08-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 1455
- Registration Number
- NCT00104013
- Locations
- 🇺🇸
Neurological Center, Fort Wayne, Indiana, United States
🇺🇸Synergy Medical, Saginaw, Michigan, United States
🇺🇸CNS Healthcare, Jacksonville, Florida, United States
18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
- Conditions
- Alzheimer Disease
- First Posted Date
- 2005-02-14
- Last Posted Date
- 2008-08-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 1306
- Registration Number
- NCT00103649
- Locations
- 🇺🇸
Neurology Clinical Research, Inc., Plantation, Florida, United States
🇺🇸Clinical Trials Research Services, Pittsburgh, Pennsylvania, United States
🇺🇸Margolin Brain Institute, Fresno, California, United States
Oxaliplatin With FOLFOX4 in Patients With Normal and Abnormal Renal Function
- First Posted Date
- 2004-10-29
- Last Posted Date
- 2009-03-30
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 43
- Registration Number
- NCT00094965
- Locations
- 🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Concomitant Radiation and Cisplatin With and Without Tirapazamine in Treatment of Advanced Head and Neck Cancer
- Conditions
- Head and Neck Neoplasms
- First Posted Date
- 2004-10-14
- Last Posted Date
- 2010-02-15
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 861
- Registration Number
- NCT00094081
- Locations
- 🇺🇸
Johns Hopkins Hospital, Baltimore, Maryland, United States
🇺🇸University of Rochester Medical Center, Rochester, New York, United States
🇺🇸H-Lee Moffitt Cancer Center and Research, Tampa, Florida, United States
HP184 in Chronic Spinal Cord Injury Subjects
- Conditions
- Spinal Cord Injury
- First Posted Date
- 2004-10-07
- Last Posted Date
- 2008-08-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 262
- Registration Number
- NCT00093275
- Locations
- 🇬🇧
Sanofi-Aventis Administrative Office, Guildford Surrey, United Kingdom
🇦🇺sanofi-aventis administrative Australia & New-Zealand administrative office, Macquarie Park, New South Wales, Australia